Probiotec Limited provided earnings guidance for the full year 2022. Based on no worsening of Covid-19 and/or economic conditions, the board expects to deliver revenue of between $175 million and $180 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 AUD | -0.33% |
|
0.00% | +2.76% |
18/06 | Probiotec Limited Announces Executive Changes | CI |
18/06 | PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited. | CI |
- Stock Market
- Equities
- PBP Stock
- News PROBIOTEC
- Probiotec Limited Provides Earnings Guidance for the Full Year 2022